姜黄来源细胞外囊泡样颗粒经眼表微环境重建促进BAC角膜损伤修复
本研究在BAC诱导的小鼠干眼角膜损伤模型中,评估姜黄来源细胞外囊泡样颗粒(CL-EVLPs)的治疗潜力。CL-EVLPs经超速离心分离表征,可被角膜上皮细胞摄取,显著加速角膜上皮修复、减少病理性新生血管、促进角膜神经再生并抑制炎症。机制涉及上调角蛋白12、下调角蛋白10,抑制VEGFA、MMP9、IL-1β、S100A8/A9及NF-κB,并升高Nrf2。
要点
- CL-EVLPs可加速BAC诱导的小鼠角膜上皮修复并抑制炎症。
- CL-EVLPs减少病理性角膜新生血管并促进角膜神经再生。
- 机制涉及上调K12、下调K10,抑制VEGFA/MMP9/IL-1β/S100A8/A9/NF-κB并升高Nrf2。
核心结论
- CL-EVLPs是一种新型天然纳米生物制剂,可恢复眼表稳态,有效增强角膜上皮再生与神经修复。
研究设计与样本
- 研究采用超速离心法分离CL-EVLPs并进行表征,在BAC局部点眼诱导的小鼠干眼角膜损伤模型中评估疗效。
- 通过临床评分、组织病理学和蛋白质组学评估角膜损伤与修复结局,并用Western blotting和实时定量PCR量化蛋白或mRNA水平。
主要发现
- CL-EVLPs呈典型碟状或杯状结构,峰值直径104 nm,平均直径138.4 ± 64.3 nm,可被角膜上皮细胞有效摄取。
- CL-EVLPs治疗显著加速角膜上皮修复、减少病理性新生血管、促进角膜神经再生并抑制炎症反应。
- 蛋白质组学显示CL-EVLPs主要参与炎症、氧化应激和免疫调节等生物学过程。
- CL-EVLPs上调角膜特异性蛋白keratin 12,下调过度增殖相关蛋白Keratin 10。
- CL-EVLPs显著抑制促血管生成VEGFA、蛋白水解酶MMP9、炎症介质IL-1β和S100A8/A9及相关转录因子NF-κB,并升高转录激活因子Nrf2表达。
临床怎么用
- CL-EVLPs作为植物来源纳米生物制剂,可能为眼表疾病提供更安全、更经济的治疗策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To investigate the therapeutic potential of Curcuma longa-derived extracellular vesicle-like particles (CL-EVLPs) in a benzalkonium chloride (BAC)-induced corneal injury model. METHODS: CL-EVLPs were isolated via ultracentrifugation and characterized. A murine dry eye model was induced by topical application of BAC. Corneal injury and repair outcomes were assessed using clinical scoring, histopathology, and proteomic analysis. Western blotting and real-time quantitative polymerase chain reaction were conducted to quantify protein or mRNA levels. Bioinformatics analysis was performed using STRING and Cytoscape software. RESULTS: CL-EVLPs, with a typical saucer- or cup-shaped structure with a peak diameter of 104 nm and an average diameter of 138.4 ± 64.3 nm, were efficiently taken up by corneal epithelial cells. Treatment with CL-EVLPs significantly accelerated corneal epithelial repair, reduced pathologic neovascularization, promoted corneal nerve regeneration, and suppressed inflammatory responses in a dry eye mouse model. Proteomic analysis revealed that CL-EVLPs are involved mainly in biological processes such as inflammation, oxidative stress, and immune regulation. Mechanistically, CL-EVLPs upregulated the cornea-specific protein keratin 12 but downregulated the hyperproliferation-associated protein Keratin 10. Additionally, we confirmed that key factors such as proangiogenic VEGFA, proteolytic MMP9, the inflammatory mediators IL-1β and S100A8/A9, and the related transcription factor NF-κB were significantly suppressed, whereas the expression levels of the transcription activator Nrf2 increased. CONCLUSIONS: CL-EVLPs represent a novel natural nanobiologic that restores ocular surface homeostasis, effectively enhancing corneal epithelial regeneration and neural repair in the ocular surface microenvironment. This study provides a foundation for the development of plant-derived EVLPs as a safer and more economical therapeutic strategy for ocular surface disorders.
引用
- Fu M, Peng D, Xu Y, et al. CL-EVLPs Promote Corneal Repair in a BAC-Induced Corneal Injury Model via Ocular Microenvironment Reconstruction. Invest Ophthalmol Vis Sci. 2026. PMID: 41773773. doi:10.1167/iovs.67.3.4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。